Our recents articles

Explore our blog for expert insights, latest updates, and in-depth articles on biocompatibility, E&L risk analysis, and related innovations.

Avisulting offers specialized support in USP665

par avisulting | Nov 27, 2024 | General Information

Ready for USP <665> and USP <1665> by May 1, 2026Compliance with USP <665> ("Plastic Components and Systems Used to Manufacture Pharmaceutical Drug Products") and USP <1665 ("Characterization and Qualification of Plastic...

The upcoming revision of ISO 10993-1and its consequences

par avisulting | Août 30, 2024 | General Information

The upcoming revision of ISO 10993-1and its consequences In the dynamic world of the pharma and biotech industries using medical devices for drug administration, adopting a risk-based approach is no longer just an option—it's a critical necessity for ensuring patient...

Avisulting: Leading the Way in Biocompatibility and E&L Consulting

par avisulting | Juin 29, 2024 | General Information

We are thrilled to announce the launch of Avisulting, a company founded by François Bianchi, a passionate expert with over 20 years of experience in the life sciences industry. Avisulting specializes in medical technology (MedTech), pharmaceutical and biotechnological...